Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway.
ACS Omega
; 7(30): 26425-26436, 2022 Aug 02.
Article
in En
| MEDLINE
| ID: mdl-35936488
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Omega
Year:
2022
Document type:
Article
Affiliation country:
Pakistán